This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Coeptis Therapeutics マネジメント
マネジメント 基準チェック /14
主要情報
Dave Mehalick
最高経営責任者
US$216.5k
報酬総額
| CEO給与比率 | 100.0% |
| CEO在任期間 | 1.6yrs |
| CEOの所有権 | 3.5% |
| 経営陣の平均在職期間 | データなし |
| 取締役会の平均在任期間 | 1.2yrs |
経営陣の近況
Recent updates
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$38m |
| Mar 31 2022 | n/a | n/a | -US$31m |
| Dec 31 2021 | US$217k | US$217k | -US$13m |
| Sep 30 2021 | n/a | n/a | -US$15m |
| Jun 30 2021 | n/a | n/a | -US$11m |
| Mar 31 2021 | n/a | n/a | -US$9m |
| Dec 31 2020 | US$149k | US$149k | -US$9m |
| Dec 31 2019 | US$147k | US$147k | -US$2m |
報酬と市場: Dave's total compensation ($USD216.50K) is below average for companies of similar size in the US market ($USD1.64M).
報酬と収益: Dave's compensation has increased whilst the company is unprofitable.
CEO（最高経営責任者
Dave Mehalick (53 yo)
1.6yrs
在職期間
US$216,500
報酬
Mr. David Mehalick, also known as Dave, is Chief Business Officer at Sparta Healthcare Acquisition Corp. He is a co-founder of Coeptis Therapeutics Inc. (formerly known as Vinings Holdings Inc.) (formerly...
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Co-Founder | 1.6yrs | US$216.50k | 3.52% $ 6.0m | |
| Co-Founder | 1.6yrs | US$133.50k | 5.86% $ 10.1m | |
| Co-Founder | 1.6yrs | US$205.50k | 5.86% $ 10.1m | |
| Member of Scientific and Clinical Advisory Board | less than a year | データなし | データなし | |
| Member of Scientific and Clinical Advisory Board | less than a year | データなし | データなし | |
| Member of Scientific and Clinical Advisory Board | less than a year | データなし | データなし |
1.2yrs
平均在職期間
53yo
平均年齢
経験豊富なボード: COEP's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.